Thomas Schrader studied Chemistry at Bonn University and obtained his PhD with Wolfgang Steglich. Subsequently, he joined the group of E. C. Taylor at Princeton University, USA, as a postdoc. Back in Germany, he pursued his habilitation work associated with the group of Günter Wulff at Düsseldorf University. He received a call in 2000 to become Associate Professor at Marburg University. Six years later, he moved to the University of Duisburg-Essen as a Full Professor. Thomas Schrader is the speaker of the Collaborative Research Center 1093 “Supramolecular Chemistry on Proteins”. His research focuses on the development of Supramolecular Ligands tailored for Proteins, Nucleic Acids and Membranes, which are able to interfere with their biological function. His molecular tweezers are in the preclinical stage as new drugs against neurodegenerative diseases (AD/PD).
Research Keywords & Expertise
DNA recognition
Biosupramolecular chem...
Artificial signal tran...
Broadspectrum antivira...
Fingerprints
Artificial signal transduction
Broadspectrum antivirals
DNA recognition
Short Biography
Thomas Schrader studied Chemistry at Bonn University and obtained his PhD with Wolfgang Steglich. Subsequently, he joined the group of E. C. Taylor at Princeton University, USA, as a postdoc. Back in Germany, he pursued his habilitation work associated with the group of Günter Wulff at Düsseldorf University. He received a call in 2000 to become Associate Professor at Marburg University. Six years later, he moved to the University of Duisburg-Essen as a Full Professor. Thomas Schrader is the speaker of the Collaborative Research Center 1093 “Supramolecular Chemistry on Proteins”. His research focuses on the development of Supramolecular Ligands tailored for Proteins, Nucleic Acids and Membranes, which are able to interfere with their biological function. His molecular tweezers are in the preclinical stage as new drugs against neurodegenerative diseases (AD/PD).
